Brief: Embecta Q1 Revenue USD 277.3 Million
09/02/2024 11:30
Feb 09 (Reuters) - Embecta Q1 adjusted operating income USD 77.5 million. * Q1 adjusted EBITDA USD 90.4 million * Q1 dividend USD 0.15 * Q1 adjusted gross profit USD 186.3 million * Q1 gross profit USD 185.9 million * Q1 operating income USD 45.5 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel